Abstract
The importance of the hypocretin/orexin system in vigilance control has rapidly emerged from the discovery of narcolepsy genes in canines and mice and from the findings of ligand deficiency in human narcolepsy (1–4). (An earlier anatomical study suggested this involvement [5].) Narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness, cataplexy, and dissociated manifestations of REM sleep (6), is now known to be caused by the loss of hypocretin neurotransmission. The loss could be caused either by a malfunction in hypocretin ligand production or by a loss of function of one of the two hypocretin receptors (i.e., hypocretin receptor 2/orexin 2 receptor) (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lin, L., Faraco, J., Li, R., et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376.
Nishino, S., Ripley, B., Overeem, S., Lammers, G.J., and Mignot, E. (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40.
Peyron, C., Faraco J., Rogers, W., et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991–997.
Chemelli, R.M., Willie, J.T., Sinton, C.M., et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437–451.
Peyron, C., Tighe, D.K., van den Pol, A.N., et al. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996–10,015.
Nishino, S., Okura, M., and Mignot, E. (2000) Narcolepsy: genetic predisposition and neuropharmacological mechanisms. Sleep Med. Rev. 4, 57–99.
Gélineau, J.B.E. and De la narcolepsie. (1880) Gazette des hôpitaux 53, 626–628.
Honda, Y. (1998) Clinical features of narcolepsy, in HLA in Narcolepsy (Honda, Y. and Juji, T., eds.) Springer-Verlag, Berlin, pp. 24–57.
Brown, R.E., Sergeeva, O., Eriksson, K.S., and Haas, H.L. (2001) Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40, 457–459.
Eriksson, K.S., Sergeeva, O., Brown, R.E., and Haas, H.L. (2001) Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J. Neurosci. 21, 9273–9279.
Huang, Z.L., Qu, W.M., Li, W.D., et al. (2001) Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. U S A 98, 9965–9970.
Nakamura, T., Uramura, K., Nambu, T., et al. (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873, 181–187.
Yamanaka, A., Muraki, Y., Tsujino, N., Goto, K., and Sakurai, T. (2003) Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun. 303, 120–129.
Yamanaka, A., Beuckmann, C.T., Willie, J.T., et al. (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713.
Nishino, S. (2003) The hypocretin/orexin system in health and disease. Biol. Psychiatry 54, 87–95.
Taheri, S., Sunter, D., Dakin, C., et al. (2000) Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci. Lett. 279, 109–112.
Terao, A., Peyron, C., Ding, J., et al. (2000) Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice. Sleep 23, 867–874.
Yoshida, Y., Fujiki, N., Nakajima, T., et al. (2001) Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 14, 1075–1081.
Fujiki, N., Yoshida, Y., Ripley, B., Honda, K., Mignot, E., and Nishino, S. (2001) Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12, 993–997.
Zeitzer, J.M., Buckmaster, C.L., Parker, K.J., Hauck, C.M., Lyons, D.M., and Mignot, E. (2003) Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J. Neurosci. 23, 3555–3560.
Estabrooke, I.V., McCarthy, M.T., Ko, E., et al. (2001) Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656–1662.
Hara, J., Beuckmann, C.T., Nambu, T., et al. (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345–354.
Beuckmann, C.T., Sinton, C.M., Williams, S.C., et al. (2004) Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J. Neurosci. 24, 4469–4477.
Borbély, A.A. and Wirz-Justice, A. (1982) Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum. Neurobiol. 1, 205–210.
Edgar, D.M., Dement, W.C., and Fuller, C.A. (1993) Effect of SCN-lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J. Neurosci. 13, 1065–1079.
Takahashi, J.S. (1995) Molecular neurobiology and genetics of circadian rhythems in mammals. Annu. Rev. Neurosci. 18, 531–553.
Tassi, P. and Muzet, A. (2000) Sleep inertia. Sleep Med. Rev. 4, 341–353.
Lavie, P. (1986) Ultrashort sleep-waking schedule. III. “Gates” and “forbidden zones” for sleep. Electroencephalogr. Clin. Neurophysiol. 63, 414–425.
Dijk, D.J. and Czeisler, C.A. (1994) Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci. Lett. 166, 63–68.
Zepelin, H. (1994) Mammalian sleep, in Principles and Practice of Sleep Medicine (Kryger, M.H., Roth, T., and Dement, W.C., eds.), WB Saunders, Philadelphia, pp. 69–80.
Siegel, J.M. (1994) Brainstem mechanisms generating REM sleep, Principles and Practice of Sleep Medicine (Kryger, M.H., Roth, T., and Dement, W.C., eds.), WB Saunders, Philadelphia, pp. 125–144.
Jouvet, M. (1994) Paradoxical sleep mechanisms. Sleep 17, S77–S83.
Alam, M.N., Gong, H., Alam, T., Jaganath, R., McGinty, D., and Szymusiak, R. (2002) Sleepwaking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J. Physiol. 538, 619–631.
Koyama, Y., Takahashi, K., Kodama, T., and Kayama, Y. (2003) State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking. Neuroscience 119, 1209–1219.
Koyama, Y., Honda, T., Kusakabe, M., Kayama, Y., and Sugiura, Y. (1998) In vivo electrophysiological distinction of histochemically-identified cholinergic neurons using extracellular recording and labelling in rat laterodorsal tegmental nucleus. Neuroscience 83, 1105–1112.
Cirelli, C. and Tononi, G. (2000) On the functional significance of c-fos induction during the sleep-waking cycle. Sleep 23, 53–69.
Strand, F.L. (1999) Neuropeptides: Regulators of Pysiological Processes. MIT Press, Cambridge, MA.
Ripley, B., Fujiki, N., Okura, M., Mignot, E., and Nishino, S. (2001) Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol. Dis. 8, 525–534.
Chen, C.T., Dun, S.L., Kwok, E.H., Dun, N.J., and Chang, J.K. (1999) Orexin A-like immunoreactivity in the rat brain. Neurosci. Lett. 260, 161–164.
Agnati, L.F., Bjelke, B., and Fuxe, K. (1995) Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med. Res. Rev. 15, 33–45.
Nishino, S., Ripley, B., Overeem, S., et al. (2001) Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50, 381–388.
Yoshida, Y., Fujiki, N., Maki, R.A., Schwarz, D., and Nishino, S. (2003) Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci. Lett. 346, 182–186.
Pedrazzoli, M., D’Almeida, V., Martins, P.J., et al. (2004) Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Res. 995, 1–6.
Martins, P.J., D’Almeida, V., Pedrazzoli, M., Lin, L., Mignot, E., and Tufik, S. (2004) Increased hypocretin-1 (orexin-A) levels in cerebrospinal fluid of rats after short-term forced activity. Regul. Pept. 117, 155–158.
Desarnaud, F., Murillo-Rodriguez, E., Lin, L., et al. (2004) The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 27, 851–856.
Zhang, S., Zeitzer, J.M., Yoshida, Y., et al. (2004) Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 27, 619–627.
Watts, A.G., Swanson, L.W., and Sanchez-Watts, G. (1987) Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J. Comp. Neurol. 258, 204–229.
Watts, A.G. and Swanson, L.W. (1987) Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J. Comp. Neurol. 258, 230–252.
Chou, T.C., Scammell, T.E., Gooley, J.J., Gaus, S.E., Saper, C.B., and Lu, J. (2003) Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J. Neurosci. 23, 10691–10702.
Aston-Jones, G., Chen, S., Zhu, Y., and Oshinsky, M.L. (2001) A neural circuit for circadian regulation of arousal. Nat. Neurosci. 4, 732–738.
Bernardis, L.L. and Bellinger, L.L. (1998) The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc. Soc. Exp. Biol. Med. 218, 284–306.
Deboer, T., Overeem, S., Visser, N.A., et al. (2004) Hypocretin-1 is under influence of circadian and homeostatic mechanisms. Sleep 27 (Suppl), A1–A2.
Wu, M.F., John, J., Maidment, N., Lam, H.A., and Siegel, J.M. (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1079–R1086.
Zeitzer, J.M., Buckmaster, C.L., Lyons, D.M., and Mignot, E. (2004) Locomotor-dependent and independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J. Physiol. 557, 1045–1053.
Salomon, R.M., Ripley, B., Kennedy, J.S., et al. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects. Biol. Psychiatry 54, 96–104.
Scammell, T.E., Estabrooke, I.V., McCarthy, M.T., et al. (2000) Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J. Neurosci. 20, 8620–8628.
Torterolo, P., Yamuy, J., Sampogna, S., Morales, F.R., and Chase, M.H. (2003) Hypocretinergic neurons are primarily involved in activation of the somatomotor system. Sleep 26, 25–28.
Espana, R.A., Plahn, S., and Berridge, C.W. (2002) Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res. 943, 224–236.
Sakurai, T., Amemiya, A., Ishil, M., et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585.
Kiyashchenko, L.I., Mileykovskiy, B.Y., Maidment, N., et al. (2002) Release of hypocretin (orexin) during waking and sleep states. J. Neurosci. 22, 5282–5286.
Tafti, M., Rondouin, G., Basset, A., and Billiard, M. (1992) Sleep deprevation in narcoleptic subjects: effect on sleep stages and EEG power density. Electroencephalogr. Clin. Neurophysiol. 83, 339–349.
Tafti, M., Villemin, E., Carlander, B., Besset, A., and Biliard, M. (1992) Sleep onset rapid-eye-movement episodes in narcolepsy: REM sleep pressure or nonrem-rem sleep dysregulation? J. Sleep Res. 1, 245–250.
Dantz, B., Edgar, D.M., and Dement, W.C. (1994) Circadian rhythms in narcolepsy: studies on a 90 minute day. Electrocephalogr. Clin. Neurophysiol. 90, 24–35.
Broughton, R., Dunham, W., Newman, J., Lutley, K., Dushesne, P., and Rivers, M. (1988) Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched control. Electroencephalogr. Clin. Neurophysiol. 70, 473–481.
Saper, C.B., Chou, T.C., and Scammell, T.E. (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24, 726–731.
Franken, P., Tobler, I., and Borbely, A.A. (1991) Sleep homeostasis in the rat: simulation of the time course of EEG slow-wave activity. Neurosci. Lett. 130, 141–144.
Nishino, S., Taheri, S., Black, J., Nofzinger, E., and Mignot, E. (2004) The neurobiology of sleep in relation to mental illness, in Neurobiology of Mental Illness (Charney, D.S., ed.), Oxford University Press, New York, pp. 1160–1179.
Aston-Jones, G. and Bloom, F.E. (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1, 876–886.
Trulson, M.E. and Jacobs, B.L. (1979) Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 163, 135–150.
Steininger, T.L., Alam, M.N., Gong, H., Szymusiak, R., and McGinty, D. (1999) Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res. 840, 138–147.
Horvath, T.L., Peyron, C., Diano, S., et al. (1999) Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145–159.
Eggermann, E., Serafin, M., Bayer, L., et al. (2001) Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108, 177–181.
Xi, M.-C., Morales, F.R., and Chase, M.H. (2001) Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the latero dorsal tegmental nucleus of the cat. Brain Res. 901, 259–264.
El Mansari, M., Sakai, K., and Jouvet, M. (1989) Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp. Brain Res. 76, 519–529.
Massaquoi, S.G. and McCarley, R.W. (1992) Extension of the limit cycle reciprocal interaction model of REM cycle control. An integrated sleep control model. J. Sleep Res. 1, 138–143.
Steriade, M., Datta, S., Paré, D., Oakson, G., and Curró Dossi, R. (1990) Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. 10, 2541–2559.
Velazquez-Moctezuma, J., Gillin, J.C., and Shiromani, P.J. (1989) Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation. Brain Res. 503, 128–131.
Webster, H.H. and Jones, B.E. (1988) Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states. Brain Res. 458, 285–302.
Jones, B.E. and Webster, H.H. (1988) Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. I. Effects upon the cholinergic innervation of the brain. Brain Res. 451, 13–32.
Gallopin, T., Fort, P., Eggermann, E., et al. (2000) Identification of sleep-promoting neurons in vitro. Nature 404, 992–995.
Li, Y., Gao, X.B., Sakurai, T., and van den Pol, A.N. (2002) Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36, 1169–1181.
Borbély, A.A. (1977) Sleep in the rat during food deprivation and subsequent restitution of food. Brain Res. 124, 457–471.
Danguir, J. and Nicolaidis, S. (1979) Dependence of sleep on nutrients’ availability. Physiol. Behav. 22, 735–740.
Dewasmes, G., Duchamp, C., and Minaire, Y. (1989) Sleep changes in fasting rats. Physiol. Behav. 46, 179–184.
Challet, E., Pevet, P., Vivien-Roels, B., and Malan, A. (1997) Phase-advanced daily rhythms of melatonin, body temperature, and locomotor activity in food-restricted rats fed during daytime. J. Biol. Rhythms 12, 65–79.
Williams, T.D., Chambers, J.B., Henderson, R.P., Rashotte, M.E., and Overton, J.M. (2002) Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1459–R1467.
Sakurai, T. (2002) Roles of orexins in regulation of feeding and wakefulness. Neuroreport 13, 987–995.
Borbéry, A.A. (2000) Introduction, in the Regulation of Sleep (Borbéry, A.A., Hayaishi, O., Sejnowski, A.J., and Altman, J.S., eds.), HFSP, Strasbourg, pp. 17–25.
Sheman, T.G., Akil, H., and Watson, S.J. (1984) The molecular biology of neuropeptides. Discussions in Neuroscience, vol. 6. Elsevier, Amsterdam, pp. 1–58.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Yoshida, Y., Nishino, S. (2006). Hypocretin/Orexin Tonus and Vigilance Control. In: Nishino, S., Sakurai, T. (eds) The Orexin/Hypocretin System. Contemporary Clinical Neuroscience. Humana Press. https://doi.org/10.1385/1-59259-950-8:155
Download citation
DOI: https://doi.org/10.1385/1-59259-950-8:155
Publisher Name: Humana Press
Print ISBN: 978-1-58829-444-9
Online ISBN: 978-1-59259-950-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)